Jeannene Butler
Overview
Explore the profile of Jeannene Butler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LaMontagne K, Butler J, Borowski V, Fuentes-Pesquera A, Blevitt J, Huang S, et al.
Angiogenesis
. 2009 Jun;
12(3):287-96.
PMID: 19544081
Angiogenesis is a complex process that relies on a variety of growth factors and signaling pathways to stimulate endothelial cell responses and establish functional blood vessels. Signaling through the vascular...
2.
Emanuel S, Hughes T, Adams M, Rugg C, Fuentes-Pesquera A, Connolly P, et al.
Mol Pharmacol
. 2007 Nov;
73(2):338-48.
PMID: 17975007
JNJ-28871063 is a potent and highly selective pan-ErbB kinase inhibitor from a novel aminopyrimidine oxime structural class that blocks the proliferation of epidermal growth factor receptor (EGFR; ErbB1)- and ErbB2-overexpressing...
3.
Seamon J, Rugg C, Emanuel S, Calcagno A, Ambudkar S, Middleton S, et al.
Mol Cancer Ther
. 2006 Oct;
5(10):2459-67.
PMID: 17041089
Cell cycle kinase inhibitors have advanced into clinical trials in oncology. One such molecule, JNJ-7706621, is a broad-spectrum inhibitor of the cyclin-dependent kinases and Aurora kinases that mediate G(2)-M arrest...
4.
LaMontagne K, Butler J, Marshall D, Tullai J, Gechtman Z, Hall C, et al.
Mol Cancer Ther
. 2006 Mar;
5(2):347-55.
PMID: 16505108
We investigated the significance of erythropoietin receptor (EPOR) expression following treatment with recombinant human erythropoietin (rHuEPO; epoetin alpha) and the effect of recombinant epoetins (epoetin alpha, epoetin beta, and darbepoetin...
5.
LaMontagne K, Littlewood-Evans A, Schnell C, OReilly T, Wyder L, Sanchez T, et al.
Cancer Res
. 2006 Jan;
66(1):221-31.
PMID: 16397235
FTY720, a potent immunomodulator, becomes phosphorylated in vivo (FTY-P) and interacts with sphingosine-1-phosphate (S1P) receptors. Recent studies showed that FTY-P affects vascular endothelial growth factor (VEGF)-induced vascular permeability, an important...
6.
Butler J, Lana D, Round O, LaMontagne K
Prostaglandins Other Lipid Mediat
. 2004 May;
73(1-2):29-45.
PMID: 15165029
Sphingosine 1-phosphate (S1P) is a pleiotropic lysophospholipid mediator involved in many cellular responses, including transient calcium mobilization, activation of MAP kinase signaling, inhibition of adenylyl cyclase and increased cell migration....